Matthew Palmer

3.8k total citations · 1 hit paper
61 papers, 1.9k citations indexed

About

Matthew Palmer is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Matthew Palmer has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Matthew Palmer's work include Renal Diseases and Glomerulopathies (10 papers), Advanced Radiotherapy Techniques (9 papers) and Radiation Therapy and Dosimetry (8 papers). Matthew Palmer is often cited by papers focused on Renal Diseases and Glomerulopathies (10 papers), Advanced Radiotherapy Techniques (9 papers) and Radiation Therapy and Dosimetry (8 papers). Matthew Palmer collaborates with scholars based in United States, Australia and Japan. Matthew Palmer's co-authors include Katalin Suszták, Chengxiang Qiu, Jihwan Park, Xin Sheng, Shizheng Huang, Poonam Dhillon, Rojesh Shrestha, Liming Pei, Brett A. Kaufman and Joseph A. Baur and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Genetics.

In The Last Decade

Matthew Palmer

57 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis

2019 461 citations Ki Wung Chung, Poonam Dhillon et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Palmer United States	23	627	503	492	350	345	61	1.9k
Takamitsu Inoue Japan	30	888 1.4×	106 0.2×	864 1.8×	633 1.8×	133 0.4×	230	2.9k
Galina Pizov Israel	25	766 1.2×	202 0.4×	812 1.7×	605 1.7×	228 0.7×	67	2.6k
Leena Krogerus Finland	32	359 0.6×	241 0.5×	412 0.8×	1.3k 3.8×	319 0.9×	125	3.1k
Chao Zhou China	19	490 0.8×	94 0.2×	355 0.7×	131 0.4×	126 0.4×	90	1.6k
Giuseppe Colucci Italy	27	615 1.0×	122 0.2×	1.1k 2.3×	521 1.5×	102 0.3×	123	3.7k
A.T.M.G. Tiebosch Netherlands	20	403 0.6×	288 0.6×	487 1.0×	588 1.7×	166 0.5×	53	2.3k
Kiril Trpkov Canada	32	1.8k 2.9×	567 1.1×	2.3k 4.8×	1.3k 3.7×	340 1.0×	137	4.5k
Kathleen C. Torkko United States	29	661 1.1×	57 0.1×	916 1.9×	290 0.8×	517 1.5×	46	2.6k
Gyongyi Nadasdy United States	30	1.1k 1.7×	1.0k 2.0×	326 0.7×	469 1.3×	388 1.1×	51	3.0k
Michael Sheaff United Kingdom	28	541 0.9×	264 0.5×	891 1.8×	407 1.2×	185 0.5×	98	2.7k

Countries citing papers authored by Matthew Palmer

Since Specialization

Citations

This map shows the geographic impact of Matthew Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Palmer more than expected).

Fields of papers citing papers by Matthew Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Palmer. The network helps show where Matthew Palmer may publish in the future.

Co-authorship network of co-authors of Matthew Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Palmer. A scholar is included among the top collaborators of Matthew Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Palmer. Matthew Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palmer, Matthew, et al.. (2025). Specific DNA features of the RNA polymerase I core promoter element targeted by core factor. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1868(2). 195088–195088.

Sato, Sayaka, Takashi Miwa, Damodar Gullipalli, et al.. (2025). Improved therapeutic efficacy of a bifunctional anti-C5 mAb-FH SCR1–5 fusion protein over anti-C5 mAb in an accelerated mouse model of C3 glomerulopathy. ImmunoHorizons. 9(3). 1 indexed citations

Yan, Yu, Hongbo Liu, Amin Abedini, et al.. (2024). Unraveling the epigenetic code: human kidney DNA methylation and chromatin dynamics in renal disease development. Nature Communications. 15(1). 873–873. 23 indexed citations

Palmer, Matthew, Eiko Saito, Kota Katanoda, et al.. (2024). The impact of alternate HPV vaccination and cervical screening strategies in Japan: a cost-effectiveness analysis. The Lancet Regional Health - Western Pacific. 44. 101018–101018. 5 indexed citations

Caza, Tiffany, Clarissa A. Cassol, Aaron J. Storey, et al.. (2023). Clinicopathologic Features of Antibrush Border Antibody Disease. Kidney International Reports. 9(2). 370–382. 3 indexed citations

Kim, Hangsoo, Damodar Gullipalli, Takashi Miwa, et al.. (2023). 240 MASP3 deficiency ameliorates but does not completely prevent alternative pathway complement-mediated tissue injury in a factor H mutant mouse model. Immunobiology. 228(5). 152690–152690. 1 indexed citations

Mottl, Amy K., Andrew S. Bomback, Laura H. Mariani, et al.. (2023). CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes. SHILAP Revista de lepidopterología. 3(1). 155–164. 1 indexed citations

Liu, Hongbo, Tomohito Doke, Xin Sheng, et al.. (2022). Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease. Nature Genetics. 54(7). 950–962. 102 indexed citations

Yang, Ya‐Wen, Bibek Poudel, Poonam Dhillon, et al.. (2022). Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice. Molecular Therapy. 30(7). 2491–2504. 11 indexed citations

10.

Wu, Junnan, Ziyuan Ma, Archana Raman, et al.. (2021). APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis. Immunity. 54(11). 2632–2649.e6. 63 indexed citations

11.

Gluck, Caroline, Chengxiang Qiu, Sang Youb Han, et al.. (2019). Kidney cytosine methylation changes improve renal function decline estimation in patients with diabetic kidney disease. Nature Communications. 10(1). 2461–2461. 59 indexed citations

12.

Park, Jihwan, Yuting Guan, Xin Sheng, et al.. (2019). Functional methylome analysis of human diabetic kidney disease. JCI Insight. 4(11). 59 indexed citations

13.

Chung, Ki Wung, Poonam Dhillon, Shizheng Huang, et al.. (2019). Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis. Cell Metabolism. 30(4). 784–799.e5. 461 indexed citations breakdown →

14.

Qiu, Chengxiang, Shizheng Huang, Jihwan Park, et al.. (2018). Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease. Nature Medicine. 24(11). 1721–1731. 146 indexed citations

15.

Ueda, Yoshiyasu, Imran Mohammed, Delu Song, et al.. (2017). Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. Blood. 129(9). 1184–1196. 44 indexed citations

16.

Wang, Jingya, Matthew Palmer, Stephen Bilton, et al.. (2015). Comparing Proton Beam to Intensity Modulated Radiation Therapy Planning in Esophageal Cancer. International Journal of Particle Therapy. 1(4). 866–877. 25 indexed citations

17.

Luciano, Randy L., Gilbert Moeckel, Matthew Palmer, & Mark A. Perazella. (2013). Babesiosis-Induced Acute Kidney Injury With Prominent Urinary Macrophages. American Journal of Kidney Diseases. 62(4). 801–805. 8 indexed citations

18.

Amsbaugh, Mark J., X Zhu, Matthew Palmer, et al.. (2012). Spot scanning proton therapy for craniopharyngioma. Practical Radiation Oncology. 2(4). 314–318. 5 indexed citations

19.

Steelman, Charlotte K., et al.. (2012). Nephrogenic Rest Within a Lipomyelomeningocele in a Patient with Unilateral Renal Agenesis. Fetal and Pediatric Pathology. 31(4). 260–264. 4 indexed citations

20.

Pelloski, Christopher E., Matthew Palmer, Gregory M. Chronowski, et al.. (2005). Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. International Journal of Radiation Oncology*Biology*Physics. 62(1). 131–137. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact